Synapse Open Synapse
Biology

Pharmacological chaperone treatment with Cystadane in aspartylglucosaminuria: an open-label, phase Ib/II trial

Nature Biological Sciences · · 1 min read

Here, this phase Ib/II interventional clinical trial shows that betaine/Cystadane is safe to use and significantly reduces urinary accumulation of glycoasparagines and increases aspartylglucosaminidase activity in aspartylglucosaminuria.

Same story elsewhere

Latest from Nature Biological Sciences